openPR Logo
Press release

Investigation announced for Long-Term Investors in Apyx Medical Corporation (NASDAQ: APYX)

09-03-2020 10:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential wrongdoing.

An investigation on behalf of investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential wrongdoing.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Apyx Medical Corporation.

Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Apyx Medical directors breached their fiduciary duties and caused damage to the company and its shareholders.

Clearwater, FL based Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation reported that its annual Total Revenue rose from $16.68 million in 2018 to $28.15 million in 2019 and that its Net Income of $64 million in 2018 declined to a Net Loss of $19.65 million in 2019.

On March 16, 2020, Apyx Medical Corporation announced that its financial statements for the twelve months ended December, 31 2018 and the quarterly statements for the three and nine months ended September 30, 2018 and three months ended March 31, 2019 could no longer be relied upon and would need to be restated.

Shares of Apyx Medical Corporation (APYX) declined from $8.56 per share on January 3, 2020, to as low as $2.92 per share on March 23, 2020.

Those who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Apyx Medical Corporation (NASDAQ: APYX) here

News-ID: 2127663 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Apyx

Key Platysmaplasty Treatment Market Trend for 2025-2034: Renuvion Technology And …
What Is the Future Outlook for the Platysmaplasty Treatment Market's Size and Growth Rate? In recent years, there has been impressive growth in the market size of platysmaplasty treatment. This trend will continue, with an increase from $1.08 billion in 2024 to $1.17 billion in 2025, representing a compound annual growth rate (CAGR) of 8.3%. Factors such as the aging demographic, heightened knowledge of cosmetic procedures, improvement in surgical technology,
Nonthermal Plasma Market : Growth Prospects and Business Outlook by 2030 | Apyx …
Nonthermal Plasma Market Overview - According to QYResearch New Study Report 'Nonthermal Plasma Market 2024' provides a comprehensive analysis of the industry with market insights will definitely facilitate to increase the knowledge and decision-making skills of the business, thus providing an immense opportunity for growth. Finally, this will increase the return rate and strengthen the competitive advantage within. Since it's a personalised market report, the services are catered to the particular
Investigation announced for Long-Term Investors in Apyx Medical Corporation (NAS …
An investigation on behalf of current long-term investors in shares of Apyx Medical Corporation (NASDAQ: APYX) concerning potential breaches of fiduciary duties by certain directors and officers of Apyx Medical Corporation was announced. Investors who are current long term investors in Apyx Medical Corporation (NASDAQ: APYX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for
Lawsuit filed for Investors in shares of Apyx Medical Corporation (NASDAQ: APYX)
An investor, who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), filed a lawsuit over alleged violations of Federal Securities Laws by Apyx Medical Corporation. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2022. NASDAQ: APYX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Clearwater FL based Apyx
Investigation announced for Investors in shares of Apyx Medical Corporation (NAS …
An investigation was announced over potential securities laws violations by Apyx Medical Corporation in connection with certain financial statements. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation regarding its business, its prospects and its operations were
Investigation for Investors in NASDAQ: APYX shares over potential Securities Law …
An investigation was announced on behalf of investors of Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx Medical Corporation. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation (NASDAQ: APYX regarding its